Chemistry and biology of the polyene macrolide antibiotics.

Comparative aspects of development and differentiation in actinomycetes. Bacteriol Rev (1976) 1.71

Classification of polyene antibiotics according to chemical structure and biological effects. Antimicrob Agents Chemother (1979) 1.69

Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B. Antimicrob Agents Chemother (1995) 1.42

Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis. Antimicrob Agents Chemother (1987) 1.38

Comparative chemotherapeutic activity of amphotericin B and amphotericine B methy ester. Antimicrob Agents Chemother (1975) 1.35

Antiviral effects of amphotericin B methyl ester. Antimicrob Agents Chemother (1978) 1.28

Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections. Antimicrob Agents Chemother (1987) 1.26

In vitro effects of amphotericin B on growth and ultrastructure of the amoeboflagellates Naegleria gruberi and Naegleria fowleri. Antimicrob Agents Chemother (1975) 1.25

Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis. Antimicrob Agents Chemother (1990) 1.22

Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo. Antimicrob Agents Chemother (1976) 1.16

Amphotericin B and filipin effects on L and HeLa cells: dose response. Antimicrob Agents Chemother (1977) 1.08

Molecular basis for the selective toxicity of amphotericin B for yeast and filipin for animal cells. Antimicrob Agents Chemother (1974) 0.99

Influence of antioxidants on the bioactivity of amphotericin B. Antimicrob Agents Chemother (1977) 0.97

Polyene-resistant mutants of Aspergillus fennelliae: sterol content and genetics. Antimicrob Agents Chemother (1974) 0.94

Response of yeast and mycelial phases of Histoplasma capsulatum to amphotericin B and actinomycin D. Antimicrob Agents Chemother (1975) 0.93

Fungal infection in a dissecting aneurysm of the thoracic aorta. Tex Heart Inst J (1993) 0.91

Synergistic action of amphotericin B and antioxidants against certain opportunistic yeast pathogens. Antimicrob Agents Chemother (1978) 0.87

Induction of amphotericin B-specific antibodies for use in immunoassays. Antimicrob Agents Chemother (1984) 0.85

Effect of fatty acids on action of polyene antibiotics. Antimicrob Agents Chemother (1980) 0.84

Use of a temperature-sensitive, protoplast-forming Neurospora crassa strain for the detection of antifungal antibiotics. Antimicrob Agents Chemother (1983) 0.82

Relative avidity of etruscomycin to cholesterol and ergosterol. Antimicrob Agents Chemother (1982) 0.82

Nystatin-induced changes in Saccharomyces cerevisiae. Antimicrob Agents Chemother (1975) 0.82

Amphotericin B and 5-fluorocytosine: in vitro effects on lymphocyte function. Antimicrob Agents Chemother (1978) 0.81

Antimicrobial and controlled release studies of a novel nystatin conjugated iron oxide nanocomposite. Biomed Res Int (2014) 0.79

Amphotericin B and 5-fluorocytosine: effects on cell-mediated immunity. Clin Exp Immunol (1980) 0.79

Sequence of biosynthesis of the components of the polyene macrolides candidin and candihexin: macrolide aglycones as intracellular components. Antimicrob Agents Chemother (1975) 0.78

Effect of phosphate and copper on the fermentation of hydroheptin. Appl Environ Microbiol (1985) 0.75

Effects of Polyenes, Detergents, and Other Potential Membrane Perturbants on an Osmotolerant Yeast, Saccharomyces rouxii. Appl Environ Microbiol (1982) 0.75

Letter: Vaginal candidosis. Br Med J (1976) 0.75

Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis (1972) 7.47

An enrichment method for auxotrophic yeast mutants using the antibiotic 'nystatin'. Nature (1966) 4.24

Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism). Proc Natl Acad Sci U S A (1972) 4.09

Two antifungal agents produced by a soil actinomycete. Science (1950) 3.56

Antibiotic interaction with model membranes. Annu Rev Pharmacol (1970) 3.42

Absorption of nystatin by microorganisms. J Bacteriol (1959) 3.33

Inhibition by antibiotics of the growth of bacterial and yeast protoplasts. J Bacteriol (1962) 3.05

Mechanism of protection by sterols against polyene antibiotics. J Bacteriol (1960) 2.97

Outline of details for microbiological assays of antibiotics: second revision. J Pharm Sci (1971) 2.95

The effect of monovalent cations on the inhibition of yeast metabolism by nystatin. J Gen Microbiol (1961) 2.93

The effect of oils and fatty acids on the production of filipin. Appl Microbiol (1956) 2.81

The development of resistance by candida species to polyene antibiotics in vitro. J Med Microbiol (1971) 2.79

Protection of fungi against polyene antibiotics by sterols. Science (1958) 2.66

Amphotericin B serum concentrations during therapy. Appl Microbiol (1970) 2.66

Studies on the biological properties of polyene antibiotics. Evidence for the direct interaction of filipin with cholesterol. J Biol Chem (1972) 2.47

EFFECT OF CHOLESTEROL ON THE SENSITIVITY OF MYCOPLASMA LAIDLAWII TO THE POLYENE ANTIBIOTIC FILIPIN. J Bacteriol (1965) 2.40

Location and role of sterol at nystatin-binding sites. J Bacteriol (1962) 2.31

Bioassay for hamycin and amphotericin B in serum and other biological fluids. Appl Microbiol (1969) 2.23

Effect of polyene antibiotics on protoplasts of Neurospora crassa. J Bacteriol (1962) 2.17

Amphotericin B and other polyenic antifungal antibiotics. Am J Clin Pathol (1969) 2.07

Polyene resistance and the isolation of sterol mutants in Saccharomyces cerevisiae. J Gen Microbiol (1972) 1.82

Candicidin and other polyenic antifungal antibiotics. Bull World Health Organ (1965) 1.82

Nystatin-resistant mutants of yeast: alterations in sterol content. J Bacteriol (1971) 1.81

Interaction of polyene antibiotics with natural and artificial membrane systems. Fed Proc (1967) 1.78

ACTION OF THE POLYENE ANTIBIOTICS FILIPIN, NYSTATIN AND N-ACETYLCANDIDIN ON THE YEAST CELL MEMBRANE. J Gen Microbiol (1964) 1.78

Polyene macrolide derivatives. I. N-acylation and esterification reactions with amphotericin B. J Antibiot (Tokyo) (1972) 1.77

Amphotericins A and B, antifungal antibiotics produced by a streptomycete. I. In vitro studies. Antibiot Annu (1957) 1.77

COMPARATIVE RESPONSES OF MAMMALIAN ERYTHROCYTES AND MICROBIAL PROTOPLASTS TO POLYENE ANTIBIOTICS AND VITAMIN A. Arch Biochem Biophys (1963) 1.73

Physiological properties of mutagen-induced variants of Candida albicans resistant to polyene antibiotics. J Med Microbiol (1972) 1.71

Biologically active N-acyl derivatives of polyene macrolide antifungal antibiotics. Antibiot Chemother (Northfield) (1961) 1.68

The development of strains of Candida albicans and Coccidioides immitis, which are resistant to amphotericin B. Antibiot Annu (1959) 1.65

Interaction of filipin and derivatives with erythrocyte membranes and lipid dispersions: electron microscopic observations. Biochim Biophys Acta (1967) 1.63

Resistance studies with nystatin. Antibiot Annu (1957) 1.63

The interaction of polyene antibiotics with thin lipid membranes. J Gen Physiol (1968) 1.62

Effect of high concentrations of nystatin upon glycolysis and cellular permeability in yeast. Proc Soc Exp Biol Med (1961) 1.58

Induced resistance of Candida species to nystatin and amphotericin B. Antibiot Annu (1958) 1.55

The effect of pH and of temperature on the stability and bioactivity of nystatin and amphotericin B. J Pharm Pharmacol (1973) 1.55

Polyene macrolide derivatives. II. Physical-chemical properties of polyene macrolide esters and their water soluble salts. J Antibiot (Tokyo) (1972) 1.52

The use of amphotericin B in man. JAMA (1962) 1.52

Biochemical and genetic aspects of nystatin resistance in saccharomyces cerevisiae. J Bacteriol (1972) 1.51

Polyene macrolide derivatives. 3. Biological properties of polyene macrolide ester salts. J Antibiot (Tokyo) (1972) 1.47

The effect of polyene macrolides on the prostate gland and canine prostatic hyperplasia. Proc Natl Acad Sci U S A (1968) 1.43

Effect of rapid intravenous infusion on serum concentrations of amphotericin B. Appl Microbiol (1971) 1.43

Resistance studies of Candida albicans, with special reference to two patients subjected to prolonged antimycotic treatment. Odontol Tidskr (1968) 1.40

Intracellular Loss of Potassium in Candida albicans After Exposure to Polyene Antifungal Antibiotics. Appl Microbiol (1966) 1.37

DEVELOPMENT OF RESISTANCE TO POLYENE ANTIBIOTICS IN CANDIDA ALBICANS. J Bacteriol (1965) 1.35

Selection and isolation of auxotrophic yeast mutants with the aid of antibiotics. J Bacteriol (1959) 1.34

Effects of four components of the polyene antibiotic, filipin, on phospholipid spherules (liposomes) and erythrocytes. J Biol Chem (1968) 1.31

A genetic analysis of resistance to nystatin in Saccharomyces cerevisiae. Genet Res (1967) 1.28

An experimental model of amphotericin B nephrotoxicity with renal tubular acidosis. J Lab Clin Med (1971) 1.27

Role of inorganic salts and mevalonic acid in the production of a tetraenic antifungal antibiotic. Antibiot Annu (1958) 1.26

Increased permeability of human erythrocytes induced by amphotericin B. J Infect Dis (1971) 1.25

Sterols from polyene-resistant mutants of Candida albicans. J Gen Microbiol (1972) 1.25

Polyene antibiotics. Science (1955) 1.25

INHIBITION OF THE PLEUROPNEUMONIA-LIKE ORGANISM MYCOPLASMA GALLISEPTICUM BY CERTAIN POLYENE ANTIFUNGAL ANTIBIOTICS. J Bacteriol (1963) 1.21

Steroid interference with antifungal activity of polyene antibiotics. Appl Microbiol (1966) 1.19

POTASSIUM LOSS FROM HUMAN ERYTHROCYTES EXPOSED TO AMPHOTERICIN B. Proc Soc Exp Biol Med (1965) 1.18

THE ACTION OF AMPHOTERICIN B ON MYCOPLASMA LAIDLAWII. Biochem Biophys Res Commun (1965) 1.17

Amphotericins A and B, antifungal antibiotics produced by a streptomycete. II. The isolation and properties of the crystalline amphotericins. Antibiot Annu (1957) 1.17

Water-soluble N-acetyl derivatives of heptaene macrolide antifungal antibiotics: microbiological studies. Antibiot Chemother (Northfield) (1961) 1.15

Chainia, a new genus of the Actinomycetales. Nature (1955) 1.15

The action of polyene antibiotics on lipid bilayer membranes in the presence of several cations and anions. Biochim Biophys Acta (1971) 1.15

Studies on candicidin biogenesis. J Antibiot (Tokyo) (1972) 1.13

THE POLYENE ANTIFUNGAL ANTIBIOTICS. Fortschr Chem Org Naturst (1963) 1.12

Hamycin: in vitro and in vivo studies. Antimicrob Agents Chemother (Bethesda) (1966) 1.11

Laboratory studies on endomycin, with special reference to its antifungal effect against Candida albicans. J Invest Dermatol (1955) 1.10

Polyene macrolide antibiotic amphotericin B. Crystal structure of the N-iodoacetyl derivative. J Am Chem Soc (1971) 1.10

Studies on antibiotic actinomycetes. IX. On Streptomyces producing a new antifungal substance mediocidin and antifungal substances of fungicidin-rimocidin-chromin group, eurocidin group and trichomycin-ascosin-candicidin group. J Antibiot (Tokyo) (1954) 1.08

The mycoticins, polyene macrolides from Streptomyces ruber. J Am Chem Soc (1967) 1.08

Alterations in Candida albicans during growth in the presence of amphotericin B. Antibiot Chemother (Northfield) (1959) 1.07

AMPHOTERICIN B TOXICITY; CHANGES IN RENAL MORPHOLOGY. Ann Intern Med (1964) 1.06

Anaerobic growth, ergosterol content and sensitivity to a polyene antibiotic, of the yeast Schizosaccharomyces japonicus. Antonie Van Leeuwenhoek (1971) 1.06

The production of polyenic antibiotics by soil streptomycetes. J Gen Microbiol (1957) 1.05

ANEMIA INDUCED BY AMPHOTERICIN B. JAMA (1964) 1.05

The biosynthesis of the macrolide antibiotic lucensomycin. J Antibiot (Tokyo) (1969) 1.05

Sterol accumulation in a mutant of Saccharomyces cerevisiae defective in ergosterol production. Biochem Biophys Res Commun (1971) 1.04

Evidence for a mucosal effect of aldosterone on sodium transport in the toad bladder. J Clin Invest (1966) 1.04

Survey of the production of polyenic substances by soil streptomycetes. Antibiot Annu (1957) 1.03

The filipin complex. Biochemistry (1968) 1.02

BINDING OF NYSTATIN BY MYCOPLASMA (PLEUROPNEUMONIA-LIKE ORGANISMS). Biochim Biophys Acta (1963) 1.02

Polyene antibiotics. V. Characterization of components of the filipin complex by mass spectrometry. J Antibiot (Tokyo) (1970) 1.01

Clinical and laboratory studies of a new micronized preparation of hamycin in systemic mycoses in man. Antimicrob Agents Chemother (Bethesda) (1967) 0.99

IN VIVO ACTIVITY OF COLLOIDAL HAMYCIN, AN ANTIFUNGAL ANTIBOTIC. Proc Soc Exp Biol Med (1964) 0.97

[Optimization of the selection of mutants of Saccharomyces cerevisiae by nystatin]. Ann Inst Pasteur (Paris) (1971) 0.97

Action of amphotericin B on the toad bladder: evidence for sodium transport along two pathways. J Physiol (1968) 0.97

On a new antifungal substance, mediocidin, and other antifungal substances of Streptomyces with three characteristic absorption maxima. J Antibiot (Tokyo) (1954) 0.95

Studies on the mechanism of action of calciferol. II. Effects of the polyene antibiotic, filipin, on vitamin D-mediated calcium transport. J Biol Chem (1970) 0.94

Pimaricin, a new antifungal antibiotic. Antibiot Annu (1958) 0.94

Mycoticin, a new antifungal antibiotic. J Invest Dermatol (1954) 0.94

A new antifungal antibiotic, pentamycin. J Antibiot (Tokyo) (1958) 0.93

[New heptane macrolides. I. Characterization and analysis]. Tetrahedron (1970) 0.93

The polyene antifungal antibiotics. Hindustan Antibiot Bull (1960) 0.93

AMPHOTERICIN B TOXICITY; REVIEW OF SELECTED ASPECTS OF PHARMACOLOGY. Ann Intern Med (1964) 0.93

Genetically controlled cross resistance to polyene antibiotics in Saccharomyces cerevisiae. Nature (1968) 0.92

AMPHOTERICIN B TOXICITY; GENERAL SIDE EFFECTS. Ann Intern Med (1964) 0.92

Macrolide antibiotic studies. XVI. The structure of nystatin. Tetrahedron Lett (1970) 0.92

[New heptane-macrolides. II. Basic skeleton, position of functional groups and structure of the aglycones]. Tetrahedron (1970) 0.92

The effects of amphotericin B on yeast metabolism. J Pharmacol Exp Ther (1960) 0.91

Fluorescence of lucensomycin upon binding to erythrocyte ghosts. FEBS Lett (1971) 0.90

Fungimycin, biogenesis of its aromatic moiety. J Antibiot (Tokyo) (1972) 0.88

Cefotoxime (HR 756) a new cephalosporin with exceptional broad-spectrum activity in vitro. J Antimicrob Chemother (1978) 4.83

World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet (1989) 4.06

Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother (1984) 3.35

Trimethoprim and rifampicin: in vitro activities separately and in combination. J Antimicrob Chemother (1975) 2.93

Interaction of cephaloridine with penicillinase-producing gram-negative bacteria. Nature (1965) 2.75

The mysterious "urethral syndrome". BMJ (1991) 2.54

Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology. Antimicrob Agents Chemother (1974) 2.40

Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin. Br Med J (1973) 2.23

Haemophilus influenzae and H. parainfluenzae as urinary pathogens. J Infect (1990) 2.23

In-vitro microbiological activities of DuP 105 and DuP 721, novel synthetic oxazolidinones. J Antimicrob Chemother (1988) 2.06

Hydrolysis of cephalosporins by beta-lactamases from gram-negative bacteria. Nature (1967) 1.86

Rapid screening for urease inhibitors. Invest Urol (1979) 1.81

Chemistry and biology of the polyene macrolide antibiotics. Bacteriol Rev (1973) 1.76

In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria. J Antimicrob Chemother (1992) 1.74

Physiological properties of mutagen-induced variants of Candida albicans resistant to polyene antibiotics. J Med Microbiol (1972) 1.71

Products of aminolysis and enzymic hydrolysis of the cephalosporins. Biochem J (1970) 1.70

Damaging effects of ethylenediaminetetra-acetate and penicillins on permeability barriers in Gram-negative bacteria. Biochem J (1966) 1.70

The demonstration and significance of synergism between -lactam antibiotics. J Med Microbiol (1971) 1.62

Diminished effect of gentamicin under anaerobic or hypercapnic conditions. Lancet (1976) 1.60

Bacterial resistance to penicillins and cephalosporins. J Pharm Pharmacol (1969) 1.59

Fungal sterols and the mode of action of the polyene antibiotics. Adv Appl Microbiol (1974) 1.59

The effect of pH and of temperature on the stability and bioactivity of nystatin and amphotericin B. J Pharm Pharmacol (1973) 1.55

An in vivo comparison of cefoxitin, a semi-synthetic cephamycin, with cephalothin. J Antibiot (Tokyo) (1974) 1.47

A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts. Sabouraudia (1972) 1.46

The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2' synthesis, and beta-lactamase production in Staphylococcus aureus. J Antimicrob Chemother (1998) 1.44

Resistance to trimethoprim in 1978-79 compared with 1973-75. J Clin Pathol (1981) 1.40

A concise biotyping system for differentiating strains of Escherichia coli. J Clin Pathol (1982) 1.39

Cephaloridine: chemical and biochemical aspects. Postgrad Med J (1967) 1.35

Antimicrobial resistance in coagulase-negative staphylococci. J Med Microbiol (1985) 1.35

"Probiotic" remedies are not what they seem. BMJ (1996) 1.34

Effect of EDTA upon bacterial permeability to benzylpenicillin. Biochem Biophys Res Commun (1965) 1.33

Screening for bacteriuria: Microstix and dipslides. Postgrad Med J (1977) 1.32

Modes of resistance to benzylpenicillin and ampicillin in twelve Klebsiella strains. J Gen Microbiol (1965) 1.32

A comparison of the in vitro activity of metronidazole, tinidazole, and nimorazole against Gram-negative anaerobic bacilli. J Clin Pathol (1975) 1.31

Non-emergence of polyene-resistant yeasts: an hypothesis. Microbios (1975) 1.31

Role of urease in the formation of infection stones: comparison of ureases from different sources. Infect Immun (1981) 1.29

Single dose and conventional treatment for acute bacterial and non-bacterial dysuria and frequency in general practice. Infection (1990) 1.26

Sterols from polyene-resistant mutants of Candida albicans. J Gen Microbiol (1972) 1.25

Inhibitors of urease as chemotherapeutic agents. Crit Rev Microbiol (1984) 1.25

Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin. Br Med J (1974) 1.24

Microbiological activity of whole and fractionated crude extracts of tea (Camellia sinensis), and of tea components. FEMS Microbiol Lett (1997) 1.23

Penicillinacylase. Bacteriol Rev (1966) 1.23

Antibacterial oxazolidinones. In vitro activity of a new analogue, E3709. Diagn Microbiol Infect Dis (1992) 1.22

Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1991) 1.21

Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience. J Antimicrob Chemother (1998) 1.20

Bacteriuria and primary biliary cirrhosis. Gut (1984) 1.20

Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus. J Antimicrob Chemother (1989) 1.16

beta-Lactamases and their clinical significance. J Antimicrob Chemother (1982) 1.16

Comparative trial of trimethoprim and co-trimoxazole in recurrent urinary infections. Infection (1983) 1.14

Can rifampicin use be safely extended? Evidence for non-emergence of resistant strains of Mycobacterium tuberculosis. Lancet (1977) 1.14

Brown- and red-pigmented Pseudomonas aeruginosa: differentiation between melanin and pyorubrin. J Med Microbiol (1975) 1.14

The effect of acetohydroxamic acid on the induction of bacterial ureases. Invest Urol (1980) 1.14

In vitro activity of combinations of antibiotics against Staphylococcus aureus resistant to gentamicin and methicillin. Infection (1985) 1.12

Comparison of the in-vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1992) 1.10

Lactobacilli do not cause frequency and dysuria syndrome. Lancet (1981) 1.09

M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteriuria. J Hepatol (1993) 1.07

The place of antibiotic prophylaxis in medicine. J Antimicrob Chemother (1975) 1.07

Effect of amoxicillin-clavulanate and cephradine on the fecal flora of healthy volunteers not exposed to a hospital environment. Antimicrob Agents Chemother (1986) 1.06

Houseplant peritonitis. Lancet (1988) 1.06

Prophylactic antibiotics for recurrent urinary tract infections. J Antimicrob Chemother (1990) 1.05

Resistance to antiseptics in methicillin and gentamicin resistant Staphylococcus aureus. Lancet (1985) 1.05

Trimethoprim-resistant bacteria: cross-resistance patterns. Microbios (1977) 1.04

Antibodies to Escherichia coli in chronic liver diseases. Gut (1975) 1.03

In vitro evaluation of ramoplanin (MDL 62198, A 16686) Eur J Clin Microbiol Infect Dis (1988) 1.03

Rifaprim (rifampicin plus trimethoprim): pharmacokinetics and effects on the normal flora of man. Biopharm Drug Dispos (1981) 1.02

The appropriate use of diagnostic services: (XII). Investigation of urinary infections in general practice: are we wasting facilities? Health Bull (Edinb) (1987) 1.02

A pilot study of 'Augmentin' in lower respiratory tract infections: pharmacokinetic and clinical results. Br J Dis Chest (1982) 1.01

Biliary excretion of erythromycin after parenteral administration. Br J Clin Pharmacol (1979) 1.00

Do anaerobes cause urinary infections? Lancet (1980) 1.00

Incidence and mechanisms of resistance to trimethoprim in clinically isolated gram-negative bacteria. Chemotherapy (1979) 1.00

Rationalization of terminology and methodology in the study of antibiotic interaction. J Antimicrob Chemother (1985) 1.00

A clinical comparison between Macrodantin and trimethoprim for prophylaxis in women with recurrent urinary infections. J Antimicrob Chemother (1985) 0.99

Antimicrobial activity of 21 anti-neoplastic agents. Br J Cancer (1984) 0.99

Changes in proton-magnetic-resonance spectra during aminolysis and enzymic hydrolysis of cephalosporins. Biochem J (1970) 0.98

Nitrite test for bacteriuria detection. Br J Gen Pract (1992) 0.98

Antibiotic activity of natural products: 1. Propolis. Microbios (1990) 0.98

Periurethral enterobacterial carriage preceding urinary infection. Lancet (1987) 0.97

Resistance to trimethoprim in Klebsiellae isolated before its introduction. J Antimicrob Chemother (1975) 0.97

Changing role of co-trimoxazole in the treatment of recurrent urinary infections: a comparison with augmentin. Br J Clin Pract (1985) 0.97

Calculating MIC50. J Antimicrob Chemother (1991) 0.96

Long-term prophylaxis of urinary infections in women: comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine. J Urol (1983) 0.96

Prevention of recurrent urinary infections in women: a comparative trial between nitrofurantoin and methenamine hippurate. J Urol (1981) 0.96

Activity of the tea component epicatechin gallate and analogues against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (2000) 0.95

Evidence that rifampicin can be used safely for non-tuberculous diseases. Thorax (1980) 0.94

A review of the antimicrobial activity of the fluoroquinolones. J Chemother (1990) 0.94

Conventional and two-dose amoxycillin treatment of bacteriuria in pregnancy and recurrent bacteriuria: a comparative study. J Antimicrob Chemother (1982) 0.92

The versatility of nitro compounds. J Antimicrob Chemother (1976) 0.92

Trimethoprim resistance and trimethoprim usage in and around The Royal Free Hospital in 1985. J Antimicrob Chemother (1986) 0.92

Understanding the MIC of beta-lactam antibiotics. J Antimicrob Chemother (1989) 0.92

Efficacy studies of probiotics: a call for guidelines. Br J Nutr (1999) 0.91

Antimicrobial agents acting against anaerobes. J Antimicrob Chemother (1975) 0.91

Comparative efficacy and tolerability of cephradine and cefuroxime axetil in the treatment of acute dysuria and/or frequency in general practice. Br J Clin Pract (1992) 0.90

Successful use of reduced dosage of cinoxacin in the treatment of recurrent urinary infection. J Antimicrob Chemother (1985) 0.90

Effect of pH and osmolality on in vitro phagocytosis and killing by neutrophils in urine. Infect Immun (1993) 0.90

Antibody-coated bacteria in urine: criterion for a positive test and its value in defining a higher risk of treatment failure. Lancet (1983) 0.90

Evaluation of the Microcult system for isolating and identifying Neisseria gonorrhoeae. J Clin Pathol (1978) 0.90

Failure of water to lyse polymorphonuclear neutrophils completely. Role of pH and implications for assessment of bacterial killing. J Immunol Methods (1989) 0.90

A comparative trial of co-trimoxazole and cephradine in patients with recurrent urinary infections. J Antimicrob Chemother (1980) 0.89

Evidence for a slowing in trimethoprim resistance during 1981--a comparison with earlier years. J Antimicrob Chemother (1983) 0.89

Methenamine and its salts as urinary tract antiseptics: variables affecting the antibacterial activity of formaldehyde, mandelic acid, and hippuric acid in vitro. Invest Urol (1977) 0.88